21. P098 Novel drug candidate for the treatment of Inflammatory Bowel Disease with unique mechanisms of action. (30th January 2023) Authors: Lee, J; Kim, G; Kim, J C; Park, J H; Han, C; Kim, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. P681 Ustekinumab therapy induced clinically meaningful improvement and remission as measured by the Inflammatory Bowel Disease Questionnaire: Results from the phase 3 UNIFI induction and maintenance studies. (25th January 2019) Authors: Sands, B E; Han, C; Zhang, H; Johanns, J; Szapary, P; Marano, C; Leong, R W; Danese, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Prevalence of positive reactions in intradermal and IgE serological allergy tests in dogs from South Australia, and the subsequent outcome of allergen‐specific immunotherapy. Issue 1 (19th November 2019) Authors: Han, C; Chan, WY; Hill, PB Journal: Australian veterinary journal Issue: Volume 98:Issue 1/2(2020) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. PTU-063 Assessment of Sleep Impairment in Patients With Crohn'S Disease: Results from the Ustekinumab Certifi Study. (4th June 2013) Authors: Gasink, C; Chan, D; Gao, L-L; Schenkel, B; Han, C Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Issue 6 (1st July 2008) Authors: Smolen, J S; Han, C; van der Heijde, D M F M; Emery, P; Bathon, J M; Keystone, E; Maini, R N; Kalden, J R; Aletaha, D; Baker, D; Han, J; Bala, M; St Clair, E W Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 6(2009) Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Research on Opportunity Maintenance Strategy of Wind Turbines Based on Incomplete Maintenance. Issue 2 (January 2021) Authors: Liu, C; Pang, R Y; Han, C; Liu, T T Journal: IOP conference series Issue: Volume 1043:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Symptomatic interferon retinopathy successfully treated by hypertension management. Issue 9 (20th August 2007) Authors: Han, C; O'Day, J Journal: British journal of ophthalmology Issue: Volume 91:Issue 9(2007) Page Start: 1250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. The Influence of Ovarian Stromal/Theca Cells During In Vitro Culture on Steroidogenesis, Proliferation and Apoptosis of Granulosa Cells Derived from the Goat Ovary. Issue 1 (21st November 2013) Authors: Qiu, M; Liu, J; Han, C; Wu, B; Yang, Z; Su, F; Quan, F; Zhang, Y Journal: Reproduction in domestic animals Issue: Volume 49:Issue 1(2014) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. The Influence of Ovarian Stromal/Theca Cells During In Vitro Culture on Steroidogenesis, Proliferation and Apoptosis of Granulosa Cells Derived from the Goat Ovary. Issue 1 (21st November 2013) Authors: Qiu, M; Liu, J; Han, C; Wu, B; Yang, Z; Su, F; Quan, F; Zhang, Y Journal: Reproduction in domestic animals Issue: Volume 49:Issue 1(2014) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. THU0360 Improvements in sleep problems and pain in patients with active ankylosing spondylitis treated with intravenous golimumab: 28-week results of the phase iii go-alive trial. (15th June 2017) Authors: Deodhar, A; Reveille, JD; Chan, EK; Peterson, S; Li, N; Hsia, E; Kim, L; Lo, KH; Harrison, DD; Han, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗